Metabolic effects of estrogens and gestagens;Metabolische Effekte der Ostrogene und Gestagene

Gynakologe

Volumn 30, Issue 4, 1997, Pages 357-369

  Kuhl, H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CYPROTERONE ACETATE; ELECTROLYTE; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; TAMOXIFEN; TIBOLONE; TRACE ELEMENT; VITAMIN;

BONE METABOLISM; CARBOHYDRATE METABOLISM; CONTRACEPTION; DRUG ACTIVITY; DRUG EFFECT; DRUG SAFETY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; METABOLISM; REVIEW;

EID: 12644315025     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00003042     Document Type: Review

References (35)

1. Kuhl H, Taubert HD (1987) Das Klimakterium. Thieme, Stuttgart
2. Lobo RA, Nguyen HN, Eggena P, Brenner PF (1988) Biologic effects of equilin sulfate in post-menopausal women. Fertil Steril 49: 234
3. Mashchak CA, Lobo RA, Dozono-Takano R, Eggena P, Nakamura RM, Brenner PF, Mishell DR (1982) Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 144. 511
4. Jones MM, Pearlman B, Marshall DH, Crilly RG, Nordin BEC (1982) Dose-dependent response of FSH, flushes and urinary calcium to oestrogen. Maturitas 4: 285
5. Jensen J (1991) Effects of sex steroids on serum lipids and lipoproteins. Bailleres Clin Obstet Gynecol 5: 867
6. Tikkanen MJ (1996) The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors. Maturitas 23: 209
7. Haines C, Chung T, Chang A, Masarei J, Tomlinson B, Wong E (1996) Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. Arch Int Med 156: 866
8. Sacks FM, McPherson R, Walsh BW (1994) Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Int Med 154: 1106
9. Shewmon DA, Stock JL, Rosen C et al. (1994) Tamoxifen and estrogen lower circulating lipoprotein (a) concentrations in healthy postmenopausal women. Arteriosclerosis 14. 1586
10. Tikkanen MJ, Kuusi T, Nikkila EA, Sipinen S (1986) Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review. Maturitas 8: 7
11. Silfverstolpe G, Gustafson A, Samsioe G, Svanborg A (1982) Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens. Maturitas 4: 103
12. Farish E, Rolton HA, Barmes JF, Hart DM (1991) Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. Br Med J 303: 694
13. Hirvonen E, Blliesen J, Sdimidt-Gollwitzer K (1990) Comparison of two hormone replacement regimens - influence on lipoproteins and bone mineral content. Maturitas 12: 127
14. Hirvonen E, Malkönen M, Manninen V (1981) Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. New Engl J Med 304: 560
15. Tonstad S, Ose L, Gorbitz C, Djoseland O, Bard JM, Fruchart JC (1995) Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. J Int Med 238: 39
16. Denke MA (1995) Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic women. Am J Med 99. 29
17. Taubert HD, Kuhl H (1995) Kontrazeption mit Hormonen. Thieme, Stuttgart
18. Fotherby K (1985) Oral contraceptives, lipids and cardiovascular disease. Contraception 31: 367
19. Godsland IF (1996) Priciples and practice of hormone reolacement therapy in women with manifest diabetes. Eur Menopause J 3 [Suppl]: 106
20. Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Ass 273: 199
21. Larsson-Cohn U, Fahraeus L, Wallentin L, Zador G (1982) Effects of the estrogenicity of levonorgestrel/ethinylestradiol combinations of the lipoprotein status. Acta Obstet Gynecol Scand [Suppl] 105: 37
22. Geola FL, Frumar AM, Tataryn IV et al. (1980) Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 51: 620
23. Ruokonen A, Kaar K (1985) Effects of desogestrel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDL-cholesterol. Eur J Obstet Gynecol Reprod Biol 20: 13
24. Schwartz U, Hammerstein J (1974) The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity. Acta Endocrinol 76 159
25. Fletcher CD, Farish E, Dagen MM, Allam BF, Hart DM (1988) Effects of conjugated equine oestrogens with and without the addition of cyclical norgestrel on serum and urine electrolytes, and the biochemical indices of bone metabolism and liver function. Maturitas 9: 347
26. Ho KKY, O'Sullivan AJ, Weissberger AJ, Kelly JJ (1996) Sex steroid regulation of growth hormone secretion. Horm Res 45 67
27. Ho KKY, Weissberger AJ (1992) Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. J Bone Min Res 7: 821
28. Nilas L, Marslev U, Overgaard K, Christiansen C (1996) Markers of bone turnover and rates of bone loss during three years' combined hormone replacement therapy. Menopause 3: 190
29. Hassager C, Jensen LT, Johansen JS et al. (1991) The carboxy-terminal propeptide of typpe I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism 40: 205
30. Christiansen C (1994) The different routes of administration and the effect of hormone replacement therapy on osteoporosis. Fertil Steril 62 152
31. de Souza MJ, Prestwood KM, Luciano AA, Miller BE, Nulsen JC (1996) A comparison of the effect of synthetic and micronized hormone replacement therapy on bone mineral density and biochemical markers of bone metabolism. Menopause 3: 140
32. el-Haji Fuleihan G, Brown EM, Curtis K, Berger MJ, Berger BM, Gleason R, LeBoff MS (1992) Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism. Arch Int Med 152: 1904
33. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ, Raisz LG (1994) The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79: 366
34. Speroff L, Rowan J, Symons J, Genant H, Wilborn W (1996) The comparative effect of bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study). J Am Med Ass 276: 1397
35. DeCherney A (1996) Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol 174: 15